Relevance of the assessment of natriuretic peptide plasma concentrations in hypertensive pregnant women. (17th August 2020)

• Record Type: Journal Article
• Authors: Gondek, Agata; Jagodzińska, Aleksandra; Pietrzak, Bronisława; Mamcarz, Artur; Cudnoch-Jędrzejewska, Agnieszka
• Is Part Of: Biomarkers. Volume 25:Number 6(2020)
• Page Start: 449
• Page End: 457
• Publication Date: 2020-08-17
• Subjects: Eclampsia -- gestational hypertension -- hypertension -- natriuretic peptides -- preeclampsia; Biochemical markers -- Periodicals; 610.28
• DOI: 10.1080/1354750X.2020.1795264
• Languages: English
• ISSNs: 1354-750X

Abstract

Abstract: Assessment of the plasma concentrations of natriuretic peptides (NPs) is widely used to diagnose and evaluate the progression of cardiac failure, and their potential as markers of preeclampsia (PE) has been examined in recent years. It has been established that plasma concentrations of NPs do not change in the course of normal pregnancy. However, elevated levels of these peptides may have a prognostic value in patients with PE. This study presents information about the relevance of NPs assessment in the evaluation of physiological pregnancy, as well as in pregnancy complicated with arterial hypertension. The most commonly examined NPs is the N-terminal fragment of the brain natriuretic peptide (NT-proBNP), and it may be prognostic marker of PE and other complications of pregnancy.